Bowling Portfolio Management LLC Eagle Pharmaceuticals, Inc. Transaction History

Bowling Portfolio Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 25, 2019	SELL	$46.61 - $58.45 $368,125 - $461,638	-7,898 Closed	0 $0
Q1 2019 Apr 18, 2019	SELL	$38.66 - $51.82 $1,237 - $1,658	-32 Reduced 0.4%	7,898 $399,000
Q4 2018 Jan 17, 2019	BUY	$36.72 - $67.73 $291,189 - $537,098	7,930 New	7,930 $319,000
Q2 2018 Aug 06, 2018	SELL	$51.25 - $76.62 $1.62 Million - $2.43 Million	-31,666 Closed	0 $0
Q1 2018 Apr 25, 2018	SELL	$52.16 - $66.86 $111,778 - $143,280	-2,143 Reduced 6.34%	31,666 $1.67 Million
Q4 2017 Jan 22, 2018	BUY	$49.6 - $60.87 $1.68 Million - $2.06 Million	33,809	33,809 $1.81 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $6.64M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Bowling Portfolio Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bowling Portfolio Management LLC with notifications on news.